1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of CDKN2A/B is a molecular marker of high-grade histology and is associated with aggressive behavior in acinic cell carcinoma
    Journal Article

    Dogan, S.; Xu, B.; Rana, S.; Chen, H.; Ghossein, R. A.; Berger, M. F.; Ho, A. L.; Katabi, N.
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Rare molecular subtypes of lung cancer
    Review

    Harada, G.; Yang, S. R.; Cocco, E.; Drilon, A.
    Nature Reviews Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: A randomized, perioperative phase 1 trial
    Journal Article

    Mellinghoff, I. K.; Lu, M.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga-Romany, I.; Peters, K. B.; Ellingson, B. M.; Rosenblum, M. K.; Chun, S.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • A single-amino acid substitution in the adaptor LAT accelerates TCR proofreading kinetics and alters T-cell selection, maintenance and function
    Journal Article

    Lo, W. L.; Kuhlmann, M.; Rizzuto, G.; Ekiz, H. A.; Kolawole, E. M.; Revelo, M. P.; Andargachew, R.; Li, Z.; Tsai, Y. L.; Marson, A.; more...
    Nature Immunology (2023)

    Fulltext@MSK | Save
  • MEN1 mutations mediate clinical resistance to menin inhibition
    Journal Article

    Perner, F.; Stein, E. M.; Wenge, D. V.; Singh, S.; Kim, J.; Apazidis, A.; Rahnamoun, H.; Anand, D.; Marinaccio, C.; Hatton, C.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Micropapillary and solid histologic patterns in N1 and N2 lymph node metastases are independent factors of poor prognosis in patients with stages II to III lung adenocarcinoma
    Journal Article

    Li, Y.; Byun, A. J.; Choe, J. K.; Lu, S.; Restle, D.; Eguchi, T.; Tan, K. S.; Saini, J.; Huang, J.; Rocco, G.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Defining morphologic features of invasion in pulmonary nonmucinous adenocarcinoma with lepidic growth: A proposal by the International Association for the study of Lung Cancer Pathology Committee
    Journal Article

    Thunnissen, E.; Beasley, M. B.; Borczuk, A.; Dacic, S.; Kerr, K. M.; Lissenberg-Witte, B.; Minami, Y.; Nicholson, A. G.; Noguchi, M.; Sholl, L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Mature T-cell and NK-cell lymphomas: Updates on molecular genetic features
    Review

    Lewis, N. E.; Sardana, R.; Dogan, A.
    International Journal of Hematology (2023)

    Fulltext@MSK | Save